Literature DB >> 12054409

What price for-profit hospitals?

Donald H Taylor1.   

Abstract

Mesh:

Year:  2002        PMID: 12054409      PMCID: PMC111214     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals.

Authors:  P J Devereaux; Peter T L Choi; Christina Lacchetti; Bruce Weaver; Holger J Schünemann; Ted Haines; John N Lavis; Brydon J B Grant; David R S Haslam; Mohit Bhandari; Terrence Sullivan; Deborah J Cook; Stephen D Walter; Maureen Meade; Humaira Khan; Neera Bhatnagar; Gordon H Guyatt
Journal:  CMAJ       Date:  2002-05-28       Impact factor: 8.262

2.  Health care professional staffing, hospital characteristics, and hospital mortality rates.

Authors:  C A Bond; C L Raehl; M E Pitterle; T Franke
Journal:  Pharmacotherapy       Date:  1999-02       Impact factor: 4.705

3.  In-hospital mortality following carotid endarterectomy.

Authors:  D J Lanska; R J Kryscio
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

4.  Hospital and pharmacy characteristics associated with mortality rates in United States hospitals.

Authors:  M E Pitterle; C A Bond; C L Raehl; T Franke
Journal:  Pharmacotherapy       Date:  1994 Sep-Oct       Impact factor: 4.705

  4 in total
  2 in total

1.  Strategic responses to fiscal constraints: a health policy analysis of hospital-based ambulatory physical therapy services in the Greater Toronto Area (GTA).

Authors:  Michel D Landry; Molly C Verrier; A Paul Williams; David Zakus; Raisa B Deber
Journal:  Physiother Can       Date:  2009-11-12       Impact factor: 1.037

2.  Availability and structure of ambulatory rehabilitation services: a survey of hospitals with designated rehabilitation beds in ontario, Canada.

Authors:  Michel D Landry; Laura A Passalent; Cheryl A Cott
Journal:  Physiother Can       Date:  2008-10-10       Impact factor: 1.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.